News
Spanish risk score predicts 30-day mortality in acute HF in ED patients
November 7, 2019
Is the MEESSI-AHF score valid to use in EDs in Switzerland?
News
Measles infection linked to impaired ‘immune memory’
November 6, 2019
Measles virus infection is associated with significant reductions in pathogen epitopes and antibody reservoirs.
News
Oral antibiotics as effective as IV for stable endocarditis patients
November 6, 2019
Can patients with left-sided endocarditis safely switch from intravenous to oral antibiotics?
News
Previously healthy patients hospitalized for sepsis show increased mortality
November 5, 2019
WASHINGTON – U.S. patients hospitalized with community-acquired sepsis had higher mortality when they had no other comorbidities.
News
New score predicts benefits of prolonged cardiac monitoring for TIA, stroke patients
November 5, 2019
How can we determine which patients would benefit from prolonged cardiac monitoring after a neurologic event?
News
Fewer bloodstream infections with FMT for C. difficile
November 4, 2019
Fecal microbiota transplantation for C. difficile infection is associated with fewer bloodstream infections and lower mortality than antibiotics.
News
Patient-reported complications regarding PICC lines after inpatient discharge
November 4, 2019
What signs and symptoms of possible complications are observed in patients who undergo placement of a peripherally inserted central catheter (PICC)?
News
How P-wave indices can improve AFib-related ischemic stroke prediction
November 1, 2019
Do the addition of P-wave indices (PWIs) measurements to the CHA2DS2-VASc score improve the ability to predict atrial fibrillation (AFib)–related ischemic stroke?
News
Vaping-linked lung injury cases near 1,900
October 31, 2019
Thirty-seven deaths from vaping-associated lung injuries have been reported in 24 states and the District of Columbia.
News
Dose-reduced NOACs may be safer than warfarin in some AFib patients
October 31, 2019
Are dose-reduced non–vitamin K antagonist oral anticoagulants (NOACs) safer or more effective than warfarin is in patients with atrial fibrillation who are eligible for a dose-reduced NOAC?